Agnt vs Genomi

Agnt and Genomi are both agent frameworks tracked by AIDiveForge. Below is a side-by-side comparison of pricing, capabilities, platforms, and ownership — sourced from each tool's live website and verified before publishing.

Agnt

AGNT is a local-first agent operating system built around an AGI loop: the agent executes a step, evaluates the result, and re-plans before moving forward — without you steering each decision. Persistent memory and skill layers mean context survives across sessions, not just within a single run. The visual workflow designer handles repeatable paths; goal-mode hands the agent an objective and lets it figure out the steps. Self-hosted deployment with Docker keeps data on your own infrastructure, which matters when your legal team has opinions about where prompts and outputs live. The custom license — not OSI-standard — is the detail that stops procurement at some organizations before the first demo.

Genomi

The core workflow is four steps: install the agent harness, point it at your raw genome file on disk, build a local SQLite index, then ask questions through whichever AI agent you already run — Claude Code, Cursor, Gemini CLI, Goose, and others are listed as compatible. Pharmacogenomics, carrier status, polygenic risk scores, nutrigenomics, and ancestry PCA projection are all covered through distinct skill modules backed by ClinVar, PharmCAT, PGS Catalog, HPO, GenCC, and 1000 Genomes reference data. The privacy architecture is explicit: raw genome data stays on disk, and only the specific evidence snippets relevant to a query cross the boundary to whatever LLM handles the response. The vendor marks this as experimental and not for clinical use — which means researchers and privacy-conscious individuals exploring personal data are the intended audience, not clinical teams expecting diagnostic-grade output.

Attribute	Agnt	Genomi
Pricing	Paid	Free
Price	$0 or $333/year per additional user for hosted version	—
Free trial	No	No
Open source	Yes	Yes
Has API	Yes	No
Self-hosted option	Yes	Yes
Platforms	Desktop (Windows, macOS, Linux), Docker, Kubernetes, headless server, VPS, homelab, Raspberry Pi	Linux, macOS, Windows (Python-based)
Released	—	2024
Pros	AGI loop (execute → evaluate → re-plan) means the agent adapts when a step returns an unexpected result, so you aren't rebuilding the workflow every time real data doesn't match the demo assumption. Persistent memory across sessions, so an agent working a multi-step task over hours or days carries context forward — without this, every run starts from zero and you hand-manage state yourself. Local-first Docker deployment with no execution-based billing, which means compliance-sensitive teams can run agents on internal data without renegotiating data processing agreements or watching a cost meter. Goal-mode lets you set an objective and let the agent sequence its own steps, so you aren't manually building every branch for tasks where the path depends on intermediate results. Plugin and subagent architecture allows parallel delegation, so work that can happen simultaneously doesn't queue behind a single-threaded pipeline.	Local-first data architecture keeps the raw genome file on disk and only sends queried evidence snippets to the LLM, so teams with strict data policies can explore personal genomic data without uploading a single variant to a third-party server. Skill modules cover pharmacogenomics via PharmCAT and ClinPGx, carrier status via ClinVar and HPO, polygenic risk via PGS Catalog, and ancestry via 1000 Genomes PCA — so a researcher doesn't have to stitch together five separate tools and manually reconcile their outputs. Each answer carries source attribution and stated evidence limits, which means you can trace a finding back to ClinVar or GenCC rather than accepting a response with no provenance — a real gap in generic LLM genomic Q&A. Agent-agnostic MCP and skills-host architecture plugs into whichever AI agent a team already runs, so there is no forced migration to a new interface or locked-in model provider. Apache-2.0 open-source license with self-hosted deployment means developers building agent-based genomic analysis tools can inspect, modify, and extend the skill layer without negotiating commercial terms.
Cons	The license is a custom non-OSI-standard document — not MIT, Apache, or GPL. Teams at enterprises or funded startups with formal open-source review processes cannot deploy to production until legal clears it, and that process adds weeks to any timeline. Some teams skip the review entirely and move to a competitor with a standard license. Community support is thin: a few hundred stars and a handful of open issues means when you hit an edge case in the re-planning loop or a plugin integration, there is precious little in forums or Stack Overflow to guide you. You are reading source code. The visual workflow designer handles linear and moderately branched paths well; deeply conditional logic — branching based on what the third or fourth agent returned — pushes against what a canvas can express cleanly. Teams building that complexity end up extending with code outside the visual layer, at which point they are maintaining two systems.	Installation requires following a source-code setup guide and configuring an AI agent to connect to the harness — non-technical users hit a wall before they ask a single question, and there is no hosted web interface to fall back on. The project is vendor-labeled experimental, which means skill coverage, reference database freshness, and edge-case handling are not production-guaranteed; teams relying on consistent outputs for any regulated or clinical-adjacent workflow will find the absence of validation documentation disqualifying and will move to a certified clinical genomics platform instead. There is no hosted API, so teams building products that need to serve genomic queries to end users must provision and maintain their own infrastructure — at scale, that maintenance burden is not accounted for in the zero-cost licensing. Evidence snippets sent to an external LLM during a query still cross a data boundary, even if the raw genome file stays local; teams operating under strict genomic data agreements need to verify that snippet-level transmission satisfies their compliance posture before deploying, and the tool provides no compliance documentation to support that review.

Bottom line

Agnt is paid while Genomi is free; only Agnt exposes a public API. Choose based on which difference matters most for your workflow.

Frequently asked questions

What is the difference between Agnt and Genomi?

Agnt is Paid and open source, while Genomi is Free and open source. Compare pricing, free trial, API, platforms, and pros/cons in the table above on AIDiveForge.

Is Agnt better than Genomi?

It depends on your workflow. Use the side-by-side attributes (pricing, open source, API, self-hosted, platforms) to decide. AIDiveForge does not rank a universal winner — we publish verified facts so you can choose.

Agnt vs Genomi: which should I pick?

Pick Agnt if its pricing model, openness, or platform fit matches your constraints; pick Genomi otherwise. Check free-trial availability on each listing if you want to test before committing.

Comparison data is sourced and verified by the AIDiveForge data pipeline. AIDiveForge is editorially independent.